Health13 hours ago
SpringWorks Therapeutics Unveils Promising Long-Term Data for OGSIVEO®
SpringWorks Therapeutics, Inc. has published new long-term efficacy and safety data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat). This oral gamma secretase inhibitor is...